UPDATE 1-FDA allows testing of Aethlon device in Ebola patients

January 2, 2015 1:46 PM

6 0

Jan 2 (Reuters) - Aethlon Medical Inc said the U.S. Food and Drug Administration had approved the testing in Ebola patients of its bio-filtration device, which was used against the deadly virus in a critically ill patient in Germany who later recovered.

The device, being developed as a broad-spectrum countermeasure against pandemic threats, filters viruses and toxins from the blood.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page